In silico analysis showed that breast cancer patients exhibited higher expression levels of PNP. Similarly, elevated levels of PNP were observed in triple negative breast cancer subtypes compared to luminal subtypes, suggesting its association with breast cancer aggressiveness. This evidence concerns the gene PNP and breast carcinoma.